RenovoRx Presents Data From Trans-Arterial Micro-Perfusion Therapy Platform

TipRanksFeb 13 08:27 ET

RenovoRx Pre-Clinical Data Announced At SIO 2025; RenovoCath Device With TAMP Technique Shows Optimized Drug Delivery In Hard-To-Treat Cancers, Utilizing Micro-CT Imaging In Porcine Model For Improved Tumor Penetration

BenzingaFeb 13 08:08 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaFeb 7 16:05 ET

RenovoRx Shares Are Trading Lower After the Company Announced the Pricing of a $12.1 Million Underwritten Public Offering of 11,523,810 Shares at $1.05 per Share.

BenzingaFeb 7 08:21 ET

Express News | Reported Earlier, RenovoRx Prices $12.1M Underwritten Public Offering Of 11,523,810 Common Stock At $1.05/Share

BenzingaFeb 7 01:29 ET

RenovoRx Plans to Use Proceeds for Working Capital, General Corporate Purposes >RNXT

Dow JonesFeb 6 20:56 ET